These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34414242)

  • 1. Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity.
    Petersson J; Askman S; Pettersson Å; Wichert S; Hellmark T; Johansson ÅCM; Hansson M
    J Immunol Res; 2021; 2021():6344344. PubMed ID: 34414242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
    Aarts CEM; Hiemstra IH; Béguin EP; Hoogendijk AJ; Bouchmal S; van Houdt M; Tool ATJ; Mul E; Jansen MH; Janssen H; van Alphen FPJ; de Boer JP; Zuur CL; Meijer AB; van den Berg TK; Kuijpers TW
    Blood Adv; 2019 Nov; 3(22):3562-3574. PubMed ID: 31738831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
    Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells.
    Westerlund J; Askman S; Pettersson Å; Hellmark T; Johansson ÅCM; Hansson M
    J Immunol Res; 2022; 2022():8077281. PubMed ID: 36438199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
    Perez C; Botta C; Zabaleta A; Puig N; Cedena MT; Goicoechea I; Alameda D; San José-Eneriz E; Merino J; Rodríguez-Otero P; Maia C; Alignani D; Maiso P; Manrique I; Lara-Astiaso D; Vilas-Zornoza A; Sarvide S; Riillo C; Rossi M; Rosiñol L; Oriol A; Blanchard MJ; Rios R; Sureda A; Martin J; Martinez R; Bargay J; de la Rubia J; Hernandez MT; Martinez-Lopez J; Orfao A; Agirre X; Prosper F; Mateos MV; Lahuerta JJ; Blade J; San-Miguel JF; Paiva B
    Blood; 2020 Jul; 136(2):199-209. PubMed ID: 32325491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
    Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
    Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen promotes multiple myeloma through enhancing the immunosuppressive activity of MDSC.
    Ozerova M; Nefedova Y
    Leuk Lymphoma; 2019 Jun; 60(6):1557-1562. PubMed ID: 30601091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
    Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
    Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter?
    Aarts CEM; Hiemstra IH; Tool ATJ; van den Berg TK; Mul E; van Bruggen R; Kuijpers TW
    Front Immunol; 2019; 10():2144. PubMed ID: 31572368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.
    Köstlin N; Schoetensack C; Schwarz J; Spring B; Marmé A; Goelz R; Brodbeck G; Poets CF; Gille C
    Front Immunol; 2018; 9():1098. PubMed ID: 29868036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
    Singel KL; Emmons TR; Khan ANH; Mayor PC; Shen S; Wong JT; Morrell K; Eng KH; Mark J; Bankert RB; Matsuzaki J; Koya RC; Blom AM; McLeish KR; Qu J; Ram S; Moysich KB; Abrams SI; Odunsi K; Zsiros E; Segal BH
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice.
    Kawano T; Shimamura M; Nakagami H; Kanki H; Sasaki T; Mochizuki H
    PLoS One; 2019; 14(5):e0215482. PubMed ID: 31048856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
    Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
    Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.
    Rahman S; Sagar D; Hanna RN; Lightfoot YL; Mistry P; Smith CK; Manna Z; Hasni S; Siegel RM; Sanjuan MA; Kolbeck R; Kaplan MJ; Casey KA
    Ann Rheum Dis; 2019 Jul; 78(7):957-966. PubMed ID: 31040119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of functionality and differentiation directed by changing gene expression patterns in myeloid-derived suppressor cells (MDSCs) in tumor microenvironment and bone marrow through early to terminal phase of tumor progression.
    Mahanti K; Saha J; Sarkar D; Pramanik A; Roy Chattopadhyay N; Bhattacharyya S
    J Leukoc Biol; 2024 Apr; 115(5):958-984. PubMed ID: 38236200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.
    Ramachandran IR; Condamine T; Lin C; Herlihy SE; Garfall A; Vogl DT; Gabrilovich DI; Nefedova Y
    Cancer Lett; 2016 Feb; 371(1):117-24. PubMed ID: 26639197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1α, 25 Dihydroxyvitamin D (1,25(OH)
    Fleet JC; Burcham GN; Calvert RD; Elzey BD; Ratliff TL
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105557. PubMed ID: 31783150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.